Calquence, also known as acalabrutinib, is a medication used in the treatment of certain types of blood cancers, such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). It belongs to a class of drugs called Bruton’s tyrosine kinase (BTK) inhibitors, which work by blocking the action of a protein that is involved in the growth and spread of cancer cells.

Calquence is typically prescribed for patients who have not responded well to other treatments or who have experienced a relapse. It is taken orally in the form of a tablet, usually once or twice a day, as directed by a healthcare provider.

As with any medication, Calquence may cause side effects. Common side effects include headache, diarrhea, fatigue, and muscle pain. More serious side effects, such as bleeding, infections, and heart rhythm problems, may also occur but are less common. It is important to report any side effects to your healthcare provider promptly.

Before starting Calquence, it is important to inform your healthcare provider about any other medications you are taking, as well as any medical conditions you may have. They will be able to determine if Calquence is the right treatment option for you and monitor your progress throughout your treatment.

Overall, Calquence has shown promising results in the treatment of certain blood cancers and has provided hope for patients who have not responded well to other therapies. If you have been prescribed Calquence, it is important to follow your healthcare provider’s instructions carefully and communicate any concerns or questions you may have.